Frontline Lenalidomide for AL Amyloidosis Involving Myocardium
NCT04298372
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Amyloidosis Cardiac
Interventions
DRUG:
Lenalidomide 25mg
Sponsor
Seoul National University Hospital